[(S)-2-Thiophen-2-yl-1-((5S,6R)-4,4,7-trioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]hept-6-ylcarbamoyl)-ethyl]-carbamic acid benzyl ester

ID: ALA113706

PubChem CID: 44342511

Max Phase: Preclinical

Molecular Formula: C20H21N3O6S2

Molecular Weight: 463.54

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H](Cc1cccs1)C(=O)N[C@@H]1C(=O)N2CCS(=O)(=O)[C@@H]12)OCc1ccccc1

Standard InChI:  InChI=1S/C20H21N3O6S2/c24-17(22-16-18(25)23-8-10-31(27,28)19(16)23)15(11-14-7-4-9-30-14)21-20(26)29-12-13-5-2-1-3-6-13/h1-7,9,15-16,19H,8,10-12H2,(H,21,26)(H,22,24)/t15-,16+,19-/m0/s1

Standard InChI Key:  YAGNDONYTVCOFN-FCEWJHQRSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  1  0  0  0  0  0999 V2000
    5.8625   -2.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8625   -3.2667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6417   -2.1875    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.0375   -2.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0375   -3.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4542   -1.8625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542   -2.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1292   -2.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6417   -3.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6917   -1.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0750   -1.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2750   -1.7000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2792    0.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2875   -0.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2292   -1.6000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2625   -1.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6125    0.6083    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.4542   -3.8417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4417   -2.8542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8625    1.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9042   -0.3292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9417    0.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8917   -1.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6875    1.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -2.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1208   -2.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7000   -1.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3375   -3.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1333   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4958   -1.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7208   -2.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7055   -1.4541    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  4  1  1  0
  5  4  1  0
  4  6  1  1
  7  6  1  0
  8  3  1  0
  9  2  1  0
 10 12  1  0
 11  7  1  0
 11 12  1  1
 13 14  1  0
 11 14  1  0
 15  3  2  0
 16  3  2  0
 17 13  1  0
 18  5  2  0
 19  7  2  0
 20 17  1  0
 21 10  2  0
 22 13  2  0
 23 10  1  0
 24 22  1  0
 25 23  1  0
 26 25  1  0
 27 26  2  0
 28 26  1  0
 29 28  2  0
 30 27  1  0
 31 29  1  0
  2  5  1  0
  8  9  1  0
 24 20  2  0
 30 31  2  0
  1 32  1  1
M  END

Associated Targets(Human)

CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctsl Cathepsin L (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.54Molecular Weight (Monoisotopic): 463.0872AlogP: 0.67#Rotatable Bonds: 7
Polar Surface Area: 121.88Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.45CX Basic pKa: CX LogP: 0.79CX LogD: 0.79
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.58Np Likeness Score: -0.87

References

1. Zhou NE, Kaleta J, Purisima E, Menard R, Micetich RG, Singh R..  (2002)  6-Acylamino-penam derivatives: synthesis and inhibition of cathepsins B, L, K, and S.,  12  (23): [PMID:12419374] [10.1016/s0960-894x(02)00766-7]

Source